<DOC>
	<DOCNO>NCT01186783</DOCNO>
	<brief_summary>MODIfY prospective , single center , open label , randomize , control two arm , Phase II-trial evaluate ability ivabradine reduce elevated heart rate Multiple Organ Dysfunction Syndrome ( MODS ) patient . The primary end point proportion patient reduction heart rate least 10 beat per minute ( bpm ) within 4 day . This trial randomize 70 patient ( men woman , age ≥ 18 year ) newly diagnose MODS ( Acute Physiology Chronic Health Evaluation ( APACHE ) II-score ≥ 20 , diagnosis within ≤ 24 hour ) , elevated heart rate ( sinus rhythm HR ≥ 90 bpm ) contraindication beta-blockers ( BBs ) . Treatment period last 4 day . All patient follow six month .</brief_summary>
	<brief_title>Reducing Elevated Heart Rate Patients With Multiple Organ Dysfunction Syndrome ( MODS ) Ivabradine</brief_title>
	<detailed_description>Background : Heart rate ( HR ) relevant prognostic value general population patient cardiovascular disease also critically ill patient multiple organ dysfunction syndrome ( MODS ) . A raised heart rate MODS patient associated bad prognosis . Beta-blocker ( BB ) administration show improve autonomic function exhibit significantly reduce mortality MODS . In case negative inotropic effect prevent administration BB MODS patient often treat catecholamine . In trial investigate , whether `` funny current '' ( If ) inhibitor ivabradine able reduce pathologically elevated heart rate MODS- patient . The investigator hypothesize critically ill patient could derive particular benefit specific HR-lowering agent ivabradine . Methods : MODIfY prospective , single center , open label , randomize , control two arm , Phase II-trial evaluate ability ivabradine reduce elevated heart rate MODS patient . The primary end point proportion patient reduction heart rate least 10 beat per minute ( bpm ) within 4 day . This trial randomize 70 patient ( men woman , age ≥18 year ) newly diagnose MODS ( Acute Physiology Chronic Health Evaluation ( APACHE ) II-score ≥20 , diagnosis within ≤24 hour ) , elevated heart rate ( sinus rhythm HR ≥90 bpm ) contraindication BBs . Treatment period last 4 day . All patient follow six month .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Multiple organ dysfunction syndrome ( APACHE II score ≥ 20 ) due coronary noncoronary etiology Multiple organ dysfunction syndrome diagnose ≤ 24 h Sinus rhythm heart rate ≥ 90bpm Existing contraindication betareceptor blockade Written inform consent identify suspected positive respect trial treatment Patients yet complete 18th year age Pregnancy , lactation Patients history preexist chronic renal failure glomerular filtration rate &lt; 30ml/min Patients malignant hyperthermia Burn patient Patients acute rejection organ transplantation Patients bleeding need transfusion Resuscitated patient suspect hypoxic brain injury Patients participate participate study within last 3 month Other type shock septic cardiogenic shock Patients severe valvular heart disease Hypersensitivity active substance excipients Severe hepatic insufficiency Sick sinus syndrome Sinuatrial block pacemakerdependency 3rd degree AV block Use potent cytochrome P450 3A4 inhibitor antifungal azole type ( ketoconazole , itraconazole ) , macrolide antibiotic ( clarithromycin , erythromycin per o , josamycin , telithromycin ) , HIV protease inhibitor ( nelfinavir , ritonavir ) nefazodone ( see Summary Product Characteristics ( SPC ) )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>heart rate</keyword>
	<keyword>multiple organ dysfunction syndrome</keyword>
	<keyword>ivabradine</keyword>
	<keyword>sepsis</keyword>
	<keyword>cardiogenic shock</keyword>
</DOC>